Tissue repair is one of the largest research areas in peptide literature. Different peptides target different tissue types and different stages of the repair cascade — angiogenesis, cellular migration, collagen synthesis, inflammation resolution. Here is the mechanism-grouped guide.
| Tissue / context | Most-cited peptides | Mechanism angle |
|---|---|---|
| Tendon / ligament | BPC-157, TB-500 | VEGF, nitric oxide, cell migration |
| Gastric mucosa / gut | BPC-157, KPV | Gastric protection, anti-inflammatory |
| Muscle / cardiac | TB-500, IGF-1 LR3, MGF | Actin dynamics, satellite cells |
| Skin / dermis | GHK-Cu, AHK-Cu, TB-500 | Collagen synthesis, fibroblast activation |
| Vascular / angiogenesis | BPC-157, VIP, TB-500 | VEGF, eNOS upregulation |
| Antimicrobial / inflammation | LL-37, KPV | Innate immunity, MC-1R/3R |
| Nerve tissue | BPC-157, BDNF | Neuroprotection, NGF |
Across preclinical tissue-repair literature, three peptides dominate by citation volume: BPC-157, TB-500, and GHK-Cu. Each occupies a distinct mechanistic niche, and the three are often combined to cover multiple repair pathways in a single research protocol.
Vascular, gastric, tendon focus. Oral bioavailability unusual among peptides. 200+ published rodent studies.
Muscle, cardiac, systemic tissue repair. Actin sequestration, cell migration. Parenteral administration.
Skin, hair, broad gene expression modulation. Modulates 4,000+ genes in cell models. Copper-bound tripeptide.
Tripeptide fragment of alpha-MSH. Studied for anti-inflammatory effects via MC-1R/3R modulation. Gut inflammation, wound healing research.
Cathelicidin antimicrobial peptide. Studied for antimicrobial activity, wound healing, innate immune modulation.
Insulin-like growth factor variants. LR3 has extended half-life; DES has enhanced local activity. Muscle and skeletal tissue research.
Mechano Growth Factor — alternative splice variant of IGF-1. Satellite cell activation in muscle injury models.
The BPC-157 + TB-500 combination is the most-cited tissue repair stack in peptide literature. SMART MD offers it pre-dosed as the Wolverine Blend (10mg of each). For skin and dermal research, the Glow Blend adds GHK-Cu to the combination.
BPC-157 is unusual among peptides in demonstrating oral bioavailability in preclinical research due to stability in gastric environments. Dihexa (cognitive category) is also orally active. Most other tissue-repair peptides (TB-500, GHK-Cu, IGF-1 variants) are typically administered parenterally in research protocols.
Yes. All listed peptides are legal to acquire for research purposes in the United States. They are classified as research-use-only — not intended for human consumption in this form. Licensed researchers and physicians may acquire them for preclinical research protocols and practice-of-medicine use.
Every SMART MD batch is verified by three independent U.S. laboratories via HPLC, mass spectrometry, and LAL endotoxin assay. Lot-specific COAs are publicly verifiable at smartmdpeptides.com/verify.
Every batch 3-lab verified. Compare our COA to any supplier's.